Association of TDP-43 proteinopathy, cerebral amyloid angiopathy, and Lewy bodies with cognitive impairment in individuals with or without Alzheimer’s disease neuropathology
Year: 2020
Type: article
Study design: Observational Study
Abstract: Alzheimer's disease patients typically present with multiple co-morbid neuropathologies at autopsy, but the impact of these pathologies on cognitive impairment during life is poorly understood. In this study, we developed cognitive trajectories for patients with common co-pathologies in the presence and absence of Alzheimer's disease neuropathology. Cognitive trajectories were modelled in a Bayesian hierarchical regression framework to estimate the effects of each neuropathology on cognitive decline as assessed by the mini-mental state examination and the clinical dementia rating scale sum of boxes scores. We show that both TDP-43 proteinopathy and cerebral amyloid angiopathy associate with cognitive impairment of similar magnitude to that associated with Alzheimer's disease neuropathology. Within our study population, 63% of individuals given the 'gold-standard' neuropathological diagnosis of Alzheimer's disease in fact possessed either TDP-43 proteinopathy or cerebral amyloid angiopathy of sufficient severity to independently explain the majority of their cognitive impairment. This suggests that many individuals diagnosed with Alzheimer's disease may actually suffer from a mixed dementia, and therapeutics targeting only Alzheimer's disease-related processes may have severely limited efficacy in these co-morbid populations.
Source: Scientific Reports
Institutions: MRC Prion Unit, University College London, Imperial College London
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $1,870
Awards: Michigan Alzheimer's Disease Core Center, UK Dementias Platform, UC Davis Alzheimer's Disease Core Center, Indiana Alzheimer Disease Center, Wake Forest Alzheimer's Disease Core Center, University of Kentucky Alzheimer's Disease Core Center, Neurobiology of Alzheimer's Disease and Aging, MRC Centre for Global Infectious Disease Analysis, G3062741013, Alzheimer's Disease Research Center, National Alzheimer's Coordinating Center, Alzheimer's Disease Research Center, Alzheimer's Disease Core Center, Cleveland Alzheimer's Disease Research Center, The Alzheimer's Disease Research Center at the University of California, Irvine, G4425758291, Stanford Alzheimer's Disease Research Center, Oregon Alzheimer's Disease Center, Rush Alzheimer's Disease Core Center, Alzheimer's Disease Core Center, Alzheimer's Disease Research Center - Overall, University of Kansas Alzheimer's Disease Core Centers, Alzheimer's Disease Research Center, Alzheimer Disease Research Center, Yale Alzheimer Disease Research Center, Arizona Alzheimer's Disease Core Center, Johns Hopkins Alzheimer's Disease Research Center, Boston University Alzheimer's Disease Center, Alzheimer's Disease Research Center, Alzheimer's Disease Core Center, Emory Alzheimer's Disease Center, University of Florida - Mt. Sinai Medical Center AD Research Center, UCSD Shiley-Marcos Alzheimer's Disease Research Center P30, Alzheimer Disease Research Center, New Approaches to Dementia Heterogeneity, Wisconsin Alzheimer's Disease Research Center, Massachusetts Alzheimer's Disease Research Center (MADRC), New Approaches to Dementia Heterogeneity
OpenAlex ID: W3082067277
